Publication:
CPT: Pharmacometrics and Systems Pharmacology Volume 12
CPT: Pharmacometrics and Systems Pharmacology Volume 12
| dc.date.accessioned | 2023-12-04T07:53:42Z | |
| dc.date.available | 2023-12-04T07:53:42Z | |
| dc.date.issued | 2023 | |
| dc.description.abstract | (Model-based prediction of effective target exposure for MEN1611 in combination with trastuzumab in HER2-positive advanced or metastatic breast cancer patients - https://doi.org/10.1002/psp4.12910) - (Mixed effects modeling of radiotherapy in combination with immune checkpoint blockade or inhibitors of the DNA damage response pathway - https://doi.org/10.1002/psp4.13026) - (Sabatolimab (MBG453) model-informed drug development for dose selection in patients with myelodysplastic syndrome/acute myeloid leukemia and solid tumors - https://doi.org/10.1002/psp4.12962) - (Copanlisib population pharmacokinetics from phase I–III studies and exposure–response relationships in combination with rituximab - https://doi.org/10.1002/psp4.13000) - (Characterizing the exposure–response relationship of idecabtagene vicleucel in patients with relapsed/refractory multiple myeloma - https://doi.org/10.1002/psp4.12922) | |
| dc.identifier.uri | http://repository.vlu.edu.vn:443/handle/123456789/10761 | |
| dc.language.iso | en_US | |
| dc.relation.issn | 21638306 | |
| dc.title | CPT: Pharmacometrics and Systems Pharmacology Volume 12 | |
| dc.type | Resource Types::text::journal | |
| dspace.entity.type | Publication | |
| oaire.citation.issue | 11 | |
| oaire.citation.volume | 12 |
Files
Original bundle
1 - 1 of 1